Table 1.
Characteristic | No. | % |
---|---|---|
Age at surgery (years) | ||
<50 | 4 | 18 |
>50 <70 | 12 | 55 |
>70 | 6 | 27 |
Ki67 status | ||
high (>15%) | 15 | 68 |
low (<15%) | 3 | 14 |
n.e. | 4 | 16 |
ER status | ||
ER+ | 21 | 95 |
ER− | 1 | 5 |
PR status | ||
PR+ | 10 | 45 |
PR− | 12 | 55 |
HER2 status | ||
HER2+ (>3+) | 3 | 14 |
HER2− | 17 | 77 |
n.e. | 2 | 9 |
ER, oestrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2; n.e., not evaluable.